Money-at-risk, not lists
Owners see rupees dying in 30/60/90 days — not a confusing expiry report nobody opens.
Pharmacy SaaS · Next.js + Supabase
Not another billing clone. We stop the silent loss Indian medical stores already feel every month — expiry write-offs, dead stock behind newer boxes, and unclaimed distributor credits.
This morning at Sri Sai Medicals
₹18,420
stock value at risk in ≤90 days
Owners see rupees dying in 30/60/90 days — not a confusing expiry report nobody opens.
Counter billing picks the earliest batch first. Overrides are logged so front-of-shelf habits stop killing stock.
Each risky batch gets a recommended move: discount, return, or push sale — plus track distributor credit notes.